TD Cowen analysts are scrutinizing the business strategies of major financial institutions, including U.S. Bancorp and Wells Fargo, while Morgan Stanley also contributes to the inquiry.
1 report, 1 independent
Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen analysts are scrutinizing the business strategies of major financial institutions, including U.S. Bancorp and Wells Fargo, while Morgan Stanley also contributes to the inquiry.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
U.S. Bancorp
American financial services holding company, parent company of U.S. Bank
-
Wells Fargo
American multinational banking and financial services company
-
Morgan Stanley
U.S. investment bank
Related events
- TD Cowen provided analyst ratings and price targets for Ardelyx, accompanied by required stock transaction filings with the SEC.
- TD Cowen and Morgan Stanley have released research reports and price targets regarding Automatic Data Processing (ADP) stock.
- TD Cowen is managing a share offering for PMV Pharma, which has been filed with the SEC and utilizes Broadridge Financial Solutions for mailing the prospectus.
- Morgan Stanley and TD Cowen are providing financial ratings and price targets for a company founded in Trivero, Italy.
- TD Cowen and Royal Bank of Canada published research reports on ChargePoint shares.
Coverage
Newest first; wire copies grouped- StockStoryU.S. Bancorp’s Q2 Earnings Call: Our Top 5 Analyst Questions U.S. Bancorp’s second quarter saw modest year-over-year revenue growth, but results were mixed relative to Wall Street expectations. Manag